Literature DB >> 28795312

Treatment of Lung Carcinosarcoma and Other Rare Histologic Subtypes of Non-small Cell Lung Cancer.

Han Yang1,2,3, Yongbin Lin1,2,3, Ying Liang4,5,6.   

Abstract

OPINION STATEMENT: Lung carcinosarcoma (PCS) and other histological subtypes of non-small cell lung cancer, such as primary pulmonary lymphoma (PPL), pulmonary carcinoid (PC), and primary pulmonary lymphoepithelioma-like carcinoma (LELC), are rare. For their low incidence, the diagnosis and treatment are still controversial. Some patients only need surgery, while others may need chemotherapy, radiotherapy, or targeted therapy. In this paper, we retrospectively reviewed the literature of some rare histological subtype of NSCLC for the recent 20 years, and try to get some conclusions.

Entities:  

Keywords:  Lung carcinosarcoma; Primary pulmonary lymphoepithelioma-like carcinoma; Primary pulmonary lymphoma; Pulmonary carcinoid

Mesh:

Substances:

Year:  2017        PMID: 28795312     DOI: 10.1007/s11864-017-0494-9

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  73 in total

1.  Bronchial carcinoid tumors: surgical management and long-term outcome.

Authors:  Pier Luigi Filosso; Ottavio Rena; Giovanni Donati; Caterina Casadio; Enrico Ruffini; Esther Papalia; Alberto Oliaro; Giuliano Maggi
Journal:  J Thorac Cardiovasc Surg       Date:  2002-02       Impact factor: 5.209

2.  Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients.

Authors:  Federico Rea; Giovanna Rizzardi; Andrea Zuin; Giuseppe Marulli; Samuele Nicotra; Renato Bulf; Marco Schiavon; Francesco Sartori
Journal:  Eur J Cardiothorac Surg       Date:  2006-11-30       Impact factor: 4.191

3.  Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients.

Authors:  J F Cordier; E Chailleux; D Lauque; M Reynaud-Gaubert; A Dietemann-Molard; J C Dalphin; F Blanc-Jouvan; R Loire
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

4.  Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization.

Authors:  J G Howe; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

Authors:  Timothy Winton; Robert Livingston; David Johnson; James Rigas; Michael Johnston; Charles Butts; Yvon Cormier; Glenwood Goss; Richard Inculet; Eric Vallieres; Willard Fry; Drew Bethune; Joseph Ayoub; Keyue Ding; Lesley Seymour; Barbara Graham; Ming-Sound Tsao; David Gandara; Kenneth Kesler; Todd Demmy; Frances Shepherd
Journal:  N Engl J Med       Date:  2005-06-23       Impact factor: 91.245

6.  Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy.

Authors:  Lori J Wirth; Mark R Carter; Pasi A Jänne; Bruce E Johnson
Journal:  Lung Cancer       Date:  2004-05       Impact factor: 5.705

7.  Lymphoepithelioma-like carcinoma of the lung: analysis of two cases for Epstein-Barr virus infection.

Authors:  M Higashiyama; O Doi; K Kodama; H Yokouchi; R Tateishi; K Horiuchi; K Mishima
Journal:  Hum Pathol       Date:  1995-11       Impact factor: 3.466

8.  Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

Authors:  Tony S Mok; Yi-Long Wu; Sumitra Thongprasert; Chih-Hsin Yang; Da-Tong Chu; Nagahiro Saijo; Patrapim Sunpaweravong; Baohui Han; Benjamin Margono; Yukito Ichinose; Yutaka Nishiwaki; Yuichiro Ohe; Jin-Ji Yang; Busyamas Chewaskulyong; Haiyi Jiang; Emma L Duffield; Claire L Watkins; Alison A Armour; Masahiro Fukuoka
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

9.  Clinical characteristics of pleomorphic carcinoma of the lung.

Authors:  Kenichiro Ito; Satoshi Oizumi; Shinichi Fukumoto; Masao Harada; Takashi Ishida; Yuka Fujita; Toshiyuki Harada; Tetsuya Kojima; Hiroshi Yokouchi; Masaharu Nishimura
Journal:  Lung Cancer       Date:  2009-07-03       Impact factor: 5.705

10.  EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy.

Authors:  Antoine Italiano; Alexis B Cortot; Marius Ilie; Ghyslaine Martel-Planche; Thibault Fabas; Daniel Pop; Jérôme Mouroux; Veronique Hofman; Paul Hofman; Florence Pedeutour
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

View more
  8 in total

1.  Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?

Authors:  Abbas Ghaderi; Shabnam Abtahi
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

2.  [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].

Authors:  Shuxian Peng; Xun Li; Qin Liu; Yingheng Zhang; Liming Zou; Xiaoli Gong; Miaomiao Wang; Xiaodong Ma
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-06-30

3.  Risk factor of brain metastases and its influence on patient prognosis after complete resection of non-small cell lung cancer.

Authors:  Jinlei Li
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

Review 4.  Polymyositis as a paraneoplastic syndrome of a patient with primary pulmonary lymphoepithelioma-like carcinoma: a case report and literature review.

Authors:  Yu Lei; Caiyang Liu; Xiu Wan; Yanhui Yang; Yi Yao; Lei Luo; Tingyu Huang; Ji Li
Journal:  J Cardiothorac Surg       Date:  2022-05-17       Impact factor: 1.522

5.  Clinical, pathological and treatment factors associated with the survival of patients with pulmonary sarcomatoid carcinoma.

Authors:  Xiaohong Liang; Yinan Cheng; Zijiang Yuan; Zhengping Yan; Quqing Li; Yuan Huang; Gaohua Feng
Journal:  Oncol Lett       Date:  2020-03-23       Impact factor: 2.967

6.  Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.

Authors:  Bingji Cao; Pengyu Wang; Lina Gu; Junfeng Liu
Journal:  Oncol Lett       Date:  2021-02-03       Impact factor: 2.967

7.  Stereotactic body radiation therapy for an octogenarian with pulmonary carcinosarcoma.

Authors:  Wei-Lun Huang; Yu-Ling Huang; Chieh-Ni Kao; Yu-Wei Liu
Journal:  Thorac Cancer       Date:  2021-03-09       Impact factor: 3.500

8.  The clinical analysis of pulmonary lymphoepithelioma-like carcinoma with epithelioid granuloma.

Authors:  Guoying Gao; Chengzhi Zhou; Guofeng Wu; Weijie Guan; Guosheng Deng; Zheng Zhu; Xinqing Lin; Xiaohong Xie; Zhanhong Xie; Jiexia Zhang; Ming Ouyang; Nanshan Zhong; Shiyue Li; Yinyin Qin
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.